Pharmaceutical industry news and analysis from Pharma Journal: drug launches, manufacturing, market access and the companies developing and supplying medicines worldwide. The commercial and scientific forces shaping the sector.
Most UK medical cannabis products are unlicensed specials. Here is how they are made, imported, regulated and dispensed under a traceable, accountable supply chain.
By James Whitfield, Manufacturing & Supply Chain Writer
The NHS has entered a decisive phase in the use of pharmacogenomics, moving from targeted pilots to routine medicines optimisation informed by genetic data. By 2026, evidence from national implementat
By Priya Raghavan, Biotech & Markets Analyst
Antimicrobial resistance is accelerating across health systems and undermining routine care. Surgical prophylaxis, oncology regimens and neonatal medicine all depend on reliable antibiotics, yet resis
By Priya Raghavan, Biotech & Markets Analyst
A single figure can sway a submission or a clinical decision. When continuous data are grouped with unequal intervals, a simple count by bin exaggerates wide ranges and hides concentrated patterns. Th
By Priya Raghavan, Biotech & Markets Analyst
Imagine a chemist walking into a clean-room suite and topping up an NMR tube with what she thinks is heavy water only to discover, hours later, that the sample signals are drowned by mineral noise. Th
By Priya Raghavan, Biotech & Markets Analyst
Pain, for many, is a deeply personal and often silent struggle. Whether it stems from surgery, chronic illness, or everyday injuries, effective relief is essential. For those turning to codeine phosph
By Priya Raghavan, Biotech & Markets Analyst
For many, osteoporosis remains a silent threat — a degenerative condition often unrecognised until a bone breaks from a simple stumble. It is one of the most widespread non-communicable diseases, affe
By Priya Raghavan, Biotech & Markets Analyst
Chronic low back pain (cLBP), defined as pain persisting for over three months, is a widespread condition affecting millions globally. It is a leading cause of disability and places a significant stra
By Priya Raghavan, Biotech & Markets Analyst
For decades, scientists have been searching for ways to make HIV prevention easier and more effective. The latest breakthrough – an annual HIV jab – might just be the most promising development yet. U
By Priya Raghavan, Biotech & Markets Analyst
For decades, aspirin has been the unsung hero of medicine cabinets across the world. From soothing headaches to reducing heart attack risks, it has earned its reputation as a household staple. However
By Priya Raghavan, Biotech & Markets Analyst
In recent years, injectable weight loss treatments have gained remarkable attention in the UK. These treatments, especially those using GLP-1 agonists, offer a promising approach for those seeking an
By Priya Raghavan, Biotech & Markets Analyst
In today's world of modern medicine, finding effective treatments that offer relief for multiple conditions is invaluable. Hydroxyzine, a widely prescribed antihistamine, stands out not only for its v
By Priya Raghavan, Biotech & Markets Analyst
In recent years, one of the most pressing concerns in healthcare has been the rising threat of superbug resistance. These drug-resistant bacteria have evolved to outsmart many of the antibiotics that
By Priya Raghavan, Biotech & Markets Analyst
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy